China Medicine Corporation
China Medicine Corporation (CHME) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
chme · pe ratio · data through Dec 31, 2009
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for China Medicine Corporation (CHME) measures how much investors pay for each dollar of the company's trailing earnings. CHME's current PE ratio of 0.28x is calculated by dividing its stock price of $0.03 by its TTM earnings per share of $0.11. −97.4% discount vs 5Y avg 11.1x
Source: FMP · /ratios-ttm · /analyst-estimates · 2009-12-31
PE Ratio History
2004 – 2009 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%5.1x
MedianQ3 · 75%38.2x
Max
At 0.28x, CHME's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
China Medicine CorporationYou CHME | $1M | 0.28x | -98.8% | $0.11 |
 Health Logic Interactive Inc. CHYPF | $0M | N/A | — | -$0.01 |
 CTT Pharmaceutical Holdings, Inc. CTTH | $2M | N/A | — | -$0.00 |
 DATATRAK International, Inc. DTRK | $0M | 3.70x | -85.0% | $0.10 |
 Epigenomics AG EPGNF | $1M | N/A | — | -$0.36 |
 Ovation Science Inc. OVATF | $1M | N/A | — | -$0.02 |
 Procyon Corporation PCYN | $2M | 45.64x | +85.0% | $0.00 |
Industry Average 2 peers with valid PE | — | 24.67x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2009-12-31Latest FY2009 | 38.22x | $0.11 | +3092.6% | |
2008-12-31 FY2008 | 1.20x | $0.60 | -76.6% | |
2007-12-31 FY2007 | 5.12x | $0.56 | +12.6% | |
2006-12-31 FY2006 | 4.55x | $0.65 | — | |
2005-12-31 FY2005 | — | $-0.00 | — | |
2004-12-31 FY2004 | 6.17x | $0.41 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for China Medicine Corporation (CHME) measures how much investors pay for each dollar of the company's trailing earnings. CHME's current PE ratio of 0.28x is calculated by dividing its stock price of $0.03 by its TTM earnings per share of $0.11.
Frequently asked questions
CHME pe ratio · 6 questionsCHME's current PE ratio is 0.28x as of 2026-06-09, based on a stock price of $0.03 and TTM EPS of $0.11. Data sourced from Financial Modeling Prep via CHME's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · China Medicine Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09